QWR-22096-20958
4 vaccinations
2 coded responses
44 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 946 / CA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
MZG-10992-24331
Child or adolescent in my care · Male · 2022-10-07
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Pfizer-BioNTech
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
-
2021-04-15
Dose 2 — Pfizer-BioNTech
- 2021-04-15
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
-
2021-07-15
Survey response — 3 months, dose 2MedDRA: Heavy menstrual bleeding, Polymenorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: A shortened menstrual cycle and significantly longer periods.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-14
-
2021-12-16
Dose 3 — Pfizer-BioNTech
-
2021-12-31
Survey response — day 14, dose 3MedDRA: Arthralgia, Joint swelling — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Swollen and painful left kneeMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Report sent to call center — day 14, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-05
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-01-27
- 2022-03-17
- 2022-06-16
-
2022-10-06
Dose 4 — Moderna
-
2022-10-07
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2023-01-05
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-15 | Pfizer-BioNTech | |
| 3 | 2021-12-16 | Pfizer-BioNTech | No |
| 4 | 2022-10-06 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: A shortened menstrual cycle and significantly longer periods.
Release 10 — day 14, dose 3
Symptoms: Swollen and painful left knee
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | · | ✓ |
| SD | Joint swelling | · | · | ✓ |
| SD | Polymenorrhoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release